5,188.00
4.00 (0.08%)
| Previous Close | 5,184.00 |
| Open | 5,188.00 |
| Volume | 2,062,767 |
| Avg. Volume (3M) | 2,218,522 |
| Market Cap | 33,410,111,488 |
| Price / Earnings (TTM) | 10.61 |
| Price / Earnings (Forward) | 15.11 |
| Price / Sales | 2.39 |
| Price / Book | 4.31 |
| 52 Weeks Range | |
| Earnings Date | 5 Mar 2026 |
| TTM Dividend Yield | 0.04% |
| Profit Margin | 8.88% |
| Operating Margin (TTM) | 21.46% |
| Diluted EPS (TTM) | 1.84 |
| Quarterly Revenue Growth (YOY) | -2.60% |
| Quarterly Earnings Growth (YOY) | -16.10% |
| Total Debt/Equity (MRQ) | 148.11% |
| Current Ratio (MRQ) | 0.560 |
| Operating Cash Flow (TTM) | 2.51 B |
| Levered Free Cash Flow (TTM) | 1.69 B |
| Return on Assets (TTM) | 8.01% |
| Return on Equity (TTM) | 17.37% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Household & Personal Products (GB) | Mixed | Mixed |
| Household & Personal Products (Global) | Mixed | Bearish | |
| Stock | RECKITT BENCKISER GROUP PLC ORD | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 1.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -4.0 |
| Average | 0.00 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| RECKITT BENCKISER GROUP PLC ORD | 33 B | 0.04% | 10.61 | 4.31 |
| PROCTER & GAMBLE CO PROCTER & G | 336 B | 2.81% | 22.78 | 6.42 |
| 0IZ8 | - | 3.37% | - | - |
| 0DQ7 | 23 B | 1.01% | 35.60 | - |
| UNILEVER PLC ORD 3.5P | 92 B | 3.57% | 18.53 | 6.74 |
| 0NZM | - | 2.03% | - | - |
|
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets. |
|
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Investment Style | Large Value |
| % Held by Insiders | 0.05% |
| % Held by Institutions | 65.27% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |